Alvocade^®

Bortezomib

Feel it in your bones

Product Information

Proprietary Name: Alvocade®
Generic Name: Bortezomib
Dosage Form: Vial
Strengths: 3.5 mg
Indications: Multiple Myeloma, Mantle Cell Lymphoma

Download Leaflet

Oncology

Alvocade®

Bortezomib is indicated for the treatment of multiple myeloma, and mantle cell lymphoma.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.